Model
Edge
CRISPR Therapeutics
0001857492
Filing Type
4
Filing Date
2/21/2022
Updated
2/22/22, 10:44 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership